KL-6 as a Tumor Marker of Primary Peritoneal Cancer in Patients with Connective Tissue Diseases. Nagashima T, Saito K, Takahashi Y, Sato K, et al. Intern Med 2024 Oct 18. doi: 10.2169/internalmedicine.4366.

Read + Share

Amedeo Smart

Independent Medical Education

Nagashima T, Saito K, Takahashi Y, Sato K, et al. KL-6 as a Tumor Marker of Primary Peritoneal Cancer in Patients with Connective Tissue Diseases. Intern Med 2024 Oct 18. doi: 10.2169/internalmedicine.4366.
PMID: 39428527